Display options
Cite
Strauss RA. Subcutaneous terbutaline as an alternative to metered-dose inhalers for asthma during the COVID-19 pandemic. J Am Coll Emerg Physicians Open. 2020;doi: 10.1002/emp2.12131.
Strauss, R. A. (2020). Subcutaneous terbutaline as an alternative to metered-dose inhalers for asthma during the COVID-19 pandemic. Journal of the American College of Emergency Physicians open, . https://doi.org/10.1002/emp2.12131
Strauss, Ronald A. "Subcutaneous terbutaline as an alternative to metered-dose inhalers for asthma during the COVID-19 pandemic." Journal of the American College of Emergency Physicians open vol. (2020). doi: https://doi.org/10.1002/emp2.12131
Strauss RA. Subcutaneous terbutaline as an alternative to metered-dose inhalers for asthma during the COVID-19 pandemic. J Am Coll Emerg Physicians Open. 2020 Jul 02; doi: 10.1002/emp2.12131. Epub 2020 Jul 02. PMID: 32838384; PMCID: PMC7361363.
Copy Download .nbib Format: NLM
Share it on

J Am Coll Emerg Physicians Open. 2020 Jul 02; doi: 10.1002/emp2.12131. Epub 2020 Jul 02.

Subcutaneous terbutaline as an alternative to metered-dose inhalers for asthma during the COVID-19 pandemic.

Journal of the American College of Emergency Physicians open

Ronald A Strauss

Affiliations

  1. Cleveland Allergy and Asthma Center Fairview Park Ohio USA.

PMID: 32838384 PMCID: PMC7361363 DOI: 10.1002/emp2.12131

[No abstract available.]

References

  1. Crit Care. 2002 Feb;6(1):30-44 - PubMed
  2. Chest. 1975 Mar;67(3):279-86 - PubMed
  3. CMAJ. 2020 Mar 30;192(13):E346 - PubMed
  4. J Am Coll Emerg Physicians Open. 2020 Apr 13;: - PubMed

Publication Types